Jens Holstein
Director of Finance/CFO bei BIONTECH SE
Vermögen: 734 580 $ am 31.03.2024
Profil
Jens Holstein bekleidet die Position des Finanzvorstands der BioNTech SE. Herr Holstein ist auch Mitglied des Vorstands von Veracyte, Inc. Zuvor war Herr Holstein Finanzvorstand der MorphoSys AG, Direktor Finanzen & Arbeit bei der Wittgensteiner Kliniken AG, Kaufmännischer Leiter Projekte & Service bei der Fresenius SE & Co. KGaA, Geschäftsführer der Fresenius ProServe GmbH, Geschäftsführer der Fresenius Kabi Deutschland GmbH, Chief Financial Officer der Fresenius Kabi Asia Pacific Ltd. und CFO-Europe & Middle East Region der Fresenius Kabi AG (alles Tochtergesellschaften der Fresenius SE & Co. KGaA), Geschäftsführer der Hospitalia Care Gmbh und kaufmännischer Leiter der Hospitalia International GmbH. Jens Holstein absolvierte sein Studium an der Universität Münster.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VERACYTE INC
0,04% | 09.06.2023 | 26 405 ( 0,04% ) | 585 135 $ | 31.03.2024 |
BIONTECH SE
0,00% | 31.12.2023 | 1 620 ( 0,00% ) | 149 445 $ | 31.03.2024 |
Aktive Positionen von Jens Holstein
| Unternehmen | Position | Beginn |
|---|---|---|
| VERACYTE, INC. | Director/Board Member | 01.08.2020 |
| BIONTECH SE | Director of Finance/CFO | 01.07.2021 |
Ehemalige bekannte Positionen von Jens Holstein
| Unternehmen | Position | Ende |
|---|---|---|
| MORPHOSYS AG | Director of Finance/CFO | 31.12.2020 |
| INFLARX N.V. | Director/Board Member | 16.07.2020 |
Fresenius Kabi Asia Pacific Ltd.
 Fresenius Kabi Asia Pacific Ltd. Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The private company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients. | Corporate Officer/Principal | 01.01.2010 |
| Wittgensteiner Kliniken AG | Director of Finance/CFO | 01.02.2006 |
| Hospitalia Care Gmbh | Corporate Officer/Principal | 01.06.2002 |
Ausbildung von Jens Holstein
| University of Münster | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| FRESENIUS SE & CO. KGAA | Health Technology |
| VERACYTE, INC. | Health Technology |
| MORPHOSYS AG | Health Technology |
| BIONTECH SE | Health Technology |
| INFLARX N.V. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
| Wittgensteiner Kliniken AG | Health Services |
Fresenius ProServe GmbH
 Fresenius ProServe GmbH Hospital/Nursing ManagementHealth Services Fresenius ProServe GmbH specializes in the medical business with hospitals and healthcare facilities. Its services range from the planning and construction of hospitals to technical and operational management in its core areas of hospital management and hospital engineering. The company is headquartered in Bad Homburg vor der Höhe, Germany. | Health Services |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Health Technology |
Hospitalia International GmbH
 Hospitalia International GmbH Medical/Nursing ServicesHealth Services Part of Else Kröner-Fresenius-Stiftung, Hospitalia International GmbH is a German company that provides health care and other related services. The private company is based in Bad Homburg, Germany. The CEOs of the company are Mirsad Midzic, Jens K. Schäkel, Rafael Garcia Feil. | Health Services |
Fresenius Kabi Asia Pacific Ltd.
Fresenius Kabi Asia Pacific Ltd. Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The private company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients. | Distribution Services |
| Hospitalia Care Gmbh | |
Fresenius Kabi Deutschland GmbH
 Fresenius Kabi Deutschland GmbH Pharmaceuticals: GenericHealth Technology Part of Fresenius SE & Co. KGaA, Fresenius Kabi Deutschland GmbH is a healthcare company based in Bad Homburg vor der Hohe, Germany. The CEOs are Steffen Roser, Christoph Funke, Tanja Greve. Fresenius Kabi creates an environment of mutual respect, encouragement, and teamwork. The German company specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The private company is also specialized in the field of oncology products supported by integrated manufacturing, regulatory, sales, marketing & distribution set up. The company has summarized their expectations towards their suppliers and business partners in a suppliers code of conduct and a business partner code of conduct. The company was founded in 1999. | Health Technology |
